Home | Cancers | Lung Cancer

Lung Cancer

Molecule Designed to Treat Lung Cancer Shows Promising Results in Mice

A multidisciplinary team led by Johns Hopkins researcher Venu Raman, Ph.D., with notable contributions from Guus Bol, Farhad Vesuna and Phuoc Tran ...

Drug-resistant lung cancer may have Achilles heel

By Bill Hathaway - Drugs introduced more than a decade ago that target mutations in a protein known as the epidermal ...

Stereotactic Ablative Radiotherapy achieves better overall survival than surgery for early lung cancer

First randomized clinical trial comparing the two therapies suggests that the non-invasive SABR treatment should be considered an alternative to surgery, especially for elderly patients and those with comorbidities ... Full story

New ASTRO guideline on definitive and adjuvant radiation therapy for locally advanced non-small cell lung cancer, nearly one-quarter of all lung cancers, featured in May-June issue of PRO

The American Society for Radiation Oncology (ASTRO) is issuing a new guideline, “Definitive and adjuvant radiotherapy in locally advanced non-small cell lung cancer: An American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.” The guideline’s executive summary is published in the May-June issue of Practical Radiation Oncology (PRO), ASTRO’s clinical practice journal. The complete guideline, which cites 35 years of data to help guide current treatment and future research, is available online as an open-access article in PRO. ... Full story

Profiling approach to enable right lung cancer treatment match

Manchester researchers have tested a new way to genetically profile lung cancer samples, potentially allowing doctors to more easily identify the most appropriate treatment for patients. ... Full story

Moffitt Cancer Center Researchers Discover Link between Inherited Genetic Variations, Outcomes of Non-Small Cell Lung Cancer Patients

TAMPA, Fla. – Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Patients diagnosed with NSCLC have a poor prognosis, with a 5-year survival rate of only 16 percent. Researchers at Moffitt Cancer Center hope to improve NSCLC patient survival with the results of a study that found that inherited genetic variations in interleukin genes are associated with improved patient survival and response to therapy. ... Full story

Prolonged Statin Use May Lower Risk of Lung Cancer Death

PHILADELPHIA — Lung cancer patients who used statins in the year prior to a lung cancer diagnosis or after a lung cancer diagnosis had a reduction in the risk of death from the disease, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. ... Full story

New targeted drug promising treatment option in resistant EGFR-positive lung cancers

Patients with lung cancer driven by a mutation in the EGFR gene frequently respond well to inhibitors that block the mutation’s activity. But eventually, those cancers become resistant to the inhibitor drugs – often because of a different EGFR mutation that the tumor cells develop. ... Full story

Immunotherapy drug shows success in treating advanced lung cancer

UCLA researchers say study also will help identify which people could respond best to treatment ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 145 | displaying: 1 - 10